Yehia Baligh R, Stewart Leslie, Momplaisir Florence, Mody Aaloke, Holtzman Carol W, Jacobs Lisa M, Hines Janet, Mounzer Karam, Glanz Karen, Metlay Joshua P, Shea Judy A
Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
University of Pennsylvania Perelman School of Medicine, 1021 Blockley Hall, 423 Guardian Drive, Philadelphia, PA, 19104, USA.
BMC Infect Dis. 2015 Jun 28;15:246. doi: 10.1186/s12879-015-0990-0.
Retention in HIV care improves survival and reduces the risk of HIV transmission to others. Multiple quantitative studies have described demographic and clinical characteristics associated with retention in HIV care. However, qualitative studies are needed to better understand barriers and facilitators.
Semi-structured interviews were conducted with 51 HIV-infected individuals, 25 who were retained in care and 26 not retained in care, from 3 urban clinics. Interview data were analyzed for themes using a modified grounded theory approach. Identified themes were compared between the two groups of interest: patients retained in care and those not retained in care.
Overall, participants identified 12 barriers and 5 facilitators to retention in HIV care. On average, retained individuals provided 3 barriers, while persons not retained in care provided 5 barriers. Both groups commonly discussed depression/mental illness, feeling sick, and competing life activities as barriers. In addition, individuals not retained in care commonly reported expensive and unreliable transportation, stigma, and insufficient insurance as barriers. On average, participants in both groups referenced 2 facilitators, including the presence of social support, patient-friendly clinic services (transportation, co-location of services, scheduling/reminders), and positive relationships with providers and clinic staff.
In our study, patients not retained in care faced more barriers, particularly social and structural barriers, than those retained in care. Developing care models where social and financial barriers are addressed, mental health and substance abuse treatment is integrated, and patient-friendly services are offered is important to keeping HIV-infected individuals engaged in care.
坚持接受艾滋病病毒治疗可提高生存率并降低将艾滋病病毒传播给他人的风险。多项定量研究描述了与坚持接受艾滋病病毒治疗相关的人口统计学和临床特征。然而,需要进行定性研究以更好地了解障碍和促进因素。
对来自3家城市诊所的51名艾滋病病毒感染者进行了半结构化访谈,其中25人坚持接受治疗,26人未坚持接受治疗。使用改良的扎根理论方法对访谈数据进行主题分析。在两组感兴趣的人群之间比较确定的主题:坚持接受治疗的患者和未坚持接受治疗的患者。
总体而言,参与者确定了12个坚持接受艾滋病病毒治疗的障碍和5个促进因素。平均而言,坚持接受治疗的个体提出了3个障碍,而未坚持接受治疗的个体提出了5个障碍。两组都普遍将抑郁/精神疾病、感觉不适和生活中的其他活动作为障碍进行讨论。此外,未坚持接受治疗的个体普遍报告昂贵且不可靠的交通、耻辱感和保险不足是障碍。平均而言,两组参与者都提到了2个促进因素,包括社会支持的存在、患者友好的诊所服务(交通、服务共址、安排/提醒)以及与提供者和诊所工作人员的积极关系。
在我们的研究中,未坚持接受治疗的患者比坚持接受治疗的患者面临更多障碍,尤其是社会和结构障碍。建立能够解决社会和经济障碍、整合心理健康和药物滥用治疗并提供患者友好服务的治疗模式对于使艾滋病病毒感染者持续接受治疗很重要。